Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review

Ghazal Aghagoli1, Benjamin Gallo Marin1, Luke B Soliman1

  • 1Warren Alpert Medical School of Brown University, Providence, Rhode Island.

Insights

COVID-19 (coronavirus disease) can significantly impact the heart, especially in patients with existing cardiovascular disease, leading to poorer outcomes. Further research is crucial for understanding cardiac effects and improving patient treatment.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Respiratory complications are common in COVID-19.
  • Cardiac involvement is increasingly recognized as a factor in severe COVID-19 outcomes.
  • Pre-existing cardiovascular disease exacerbates COVID-19 severity and mortality.

Purpose of the Study:

  • To review and synthesize current literature on the cardiac implications of COVID-19.
  • To consolidate fragmented knowledge regarding cardiovascular disease in COVID-19 patients.

Main Methods:

  • Systematic review of English-language literature.
  • Focused search on papers detailing cardiac effects of COVID-19.

Main Results:

  • COVID-19 patients with cardiovascular disease have higher ICU admission and mortality rates.
  • Reported cardiac manifestations include acute pericarditis and left ventricular dysfunction.
  • Evidence of acute myocardial injury and elevated troponin I levels observed in some patients.
  • Limited data exists on myocardial protection during cardiac surgery for COVID-19 patients.

Conclusions:

  • Current understanding of COVID-19 cardiac pathophysiology is fragmented.
  • Further studies are essential for developing clear clinical guidelines.
  • Improved understanding will lead to better treatment and patient outcomes.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
282
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
119
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
242
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
781
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
339
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
293